• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Health­care shake­up hits Wash­ing­ton, with cuts at CDC, NIH and oth­er agen­cies

3 months ago
FDA+
Law

J&J to face piv­otal hear­ing over its $8B talc set­tle­ment plan

3 months ago
Pharma
Law

ARPA-H chief is out as Trump ad­min­is­tra­tion cuts health agen­cies

3 months ago
People
Pharma

Ex­clu­sive: Drug­mak­ers plan Trump meet­ing next week amid Wash­ing­ton health shake­ups

3 months ago
Pharma
FDA+

Ko­jin Ther­a­peu­tics shuts down, cit­ing lack of in­vestor in­ter­est and com­plex sci­ence

3 months ago
People
Startups

West Phar­ma los­es two glu­cose de­vice clients but is buoyed by its GLP-1 pack­ag­ing ser­vices

3 months ago
Outsourcing
Manufacturing

Cor­bus shares dip on mixed Phase 1 sol­id tu­mor da­ta for Nectin-4 ADC

3 months ago
R&D

Ot­su­ka makes pipeline changes; Oculis re­veals $100M of­fer­ing

3 months ago
News Briefing

BioN­Tech vets raise $90M Se­ries A for bis­pe­cif­ic I&I start­up

3 months ago
Financing
R&D

How Bain’s $3.3B deal for cen­turies-old Tan­abe Phar­ma came to fruition

3 months ago
Deals
Pharma

David Schenkein re­signs from Agios’ board; Mod­er­na hires Roivant ex­ec as chief mar­ket­ing of­fi­cer

3 months ago
Peer Review

Bris­tol My­ers’ Op­du­alag stum­bles in late-stage re­sect­ed melanoma tri­al

3 months ago
R&D

Up­dat­ed: Mod­er­na re­ports $238M man­u­fac­tur­ing write-down as cuts, new vac­cines shape 2025

3 months ago
Pharma
Manufacturing

Labs fear fu­ture fund­ing cuts with Trump ad­min­is­tra­tion ac­tions in lim­bo

3 months ago
R&D
Pharma

David Bak­er's lab makes en­zymes with AI, open­ing up the pos­si­bil­i­ty of more pre­cise gene-edit­ing tools

3 months ago
AI

Known­well is bet­ting on in-per­son weight man­age­ment care

3 months ago
Health Tech

Up­dat­ed: Kennedy is con­firmed to lead HHS, putting an­ti-vac­cine ad­vo­cate and drug in­dus­try skep­tic atop US health ...

3 months ago
People
Pharma

Agios’ Pyrukynd suc­ceeds in key tri­al of rare red blood cell dis­or­der in kids

3 months ago
R&D

Syn­gene CEO de­parts; Lil­ly and Ad­van­Cell sign ra­dio­ther­a­py part­ner­ship

3 months ago
Manufacturing

Al­lay Ther­a­peu­tics rais­es $45M for on­go­ing Se­ries D; En­cod­ed’s lay­offs

3 months ago
News Briefing

Idor­sia’s Tryvio li­cens­ing ne­go­ti­a­tions col­lapse amid cash squeeze

3 months ago
Deals

Neumo­ra shakes up C-suite a month af­ter de­pres­sion drug fails first Phase 3 tri­al

3 months ago
People

Sanofi faces $250M charge af­ter J&J-part­nered vac­cine flunks late-stage test

3 months ago
Deals
R&D

Hunger-sup­press­ing biotech Aard­vark rais­es $94M in IPO

3 months ago
Financing
Startups
First page Previous page 42434445464748 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times